Search results
Tuesday 21 July 2026, 7.00pm - 8.00pm - via Zoom - Following on from a great in-person Summer meet up last month, we are pleased to invite you to come and join facilitator Suzanne Clarke and the group for their latest online social catch up.
It has recently been announced that Meira-GTx, who originally developed bota-vec and collaborated with J&J during its early clinical trials, have entered into an asset purchase agreement with J&J to acquire bota-vec and progress the program towards global regulatory filings for approval.
Saturday 11 July 2026, 12.00pm - 4.00pm - In-person - Please come and join facilitator Stuart Francis and our South Wales Peer Support Group for their first in-person get together at The Prince of Wales pub in Cardiff City Centre.
On a typical week in the stem cell lab there are many different experiments going on. Different people work on their individual projects, but we often collaborate to share ideas and help each other.
Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Ocugen have recently announced that they have completed enrolment and dosing in their pivotal phase 2/3 trial of OCU410ST ahead of schedule.
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.
